EHY-2030
Loco-regional modulated electro-hyperthermia (mEHT) device
The EHY-2030 device is intended for the adjuvant treatment of glioblastoma in a combination regimen with chemotherapy and/or radiation therapy. The newly designed device includes the Smart Electrode system and the integrated Patient Management System (PMS) and a user-friendly touch screen display with full system control. The new RF generator with impulse mode increased peak power has been developed with a new intelligently controlled step motor tuning system for rapid impedance matching to achieve shorter tuning-time.
The EHY-2030 device is a CE-marked medical device, and is intended for professional use.
-
User friendly touch screen display
Thanks to the user-friendly touch screen, the parameters and progress of the treatment can be controlled and monitored from start to stop.
-
Innovative design
When designing our treatment bed, we also paid special attention to the comfort needs of the patients. Our mattresses combined with a waterbed, as well as the manual Patient Stop Button available to patients can help the patients' pleasant well-being as they could help to overcome the anxiety caused by the treatment.
-
SMArt Electrode system
- Built-in electrode identification system and electrode ring (with lifetime management) and a counter electrode
- Continuous communication with the central controller
- Controlled surface temperature to increase patient comforta
- The precise placement of the electrodes is supported by an LED indicator
- Smart Electrode M (max. 150 W)
- Smart Electrode L (max. 250 W)
Technical specifications
Mains voltage: 100 - 230 VAC 50/60 Hz
RF power output: max. 350 W(eff) / 800 W(pp)
Nominal load: 50 Ohm
Output carrier frequency: 13,56 Mhz
Output modulating frequency: Pink noise
Required space: min. 12 m2
Recommended space: 14 m2
Weight: 200 kg
Dimensions (HxLxW): 1320 x 2500 x 1150 mm
Operating conditions:
Temperature: +15°C - +30°C
Relative air humidity: 20% - 60% (non-condensing)
Air pressure: 800 - 1060 hPa
